SII to launch first indigenous pneumonia vaccine


The vaccine is expected to be much more affordable than the existing ones manufactured by two foreign companies.

The first indigenous vaccine against pneumonia, developed by the Serum Institute of India (SII), will be launched by Union Health Minister Harsh Vardhan on Monday, says information released by the Institute here on Sunday.

According to sources, the vaccine will be much more affordable than the existing ones manufactured by two foreign companies.

In July, India’s drug regulator had granted market approval for the Pneumococcal Polysaccharide Conjugate vaccine, after reviewing the phase 1, 2 and 3 clinical trial data submitted by the Pune-based firm.

“This vaccine is used for active immunisation against invasive disease and pneumonia caused by Streptococcus pneumonia in infants,” the Health Ministry had said earlier.

You have reached your limit for free articles this month.

Subscription Benefits Include

Today’s Paper

Find mobile-friendly version of articles from the day’s newspaper in one easy-to-read list.

Unlimited Access

Enjoy reading as many articles as you wish without any limitations.

Personalised recommendations

A select list of articles that match your interests and tastes.

Faster pages

Move smoothly between articles as our pages load instantly.

Dashboard

A one-stop-shop for seeing the latest updates, and managing your preferences.

Briefing

We brief you on the latest and most important developments, three times a day.

Support Quality Journalism.

*Our Digital Subscription plans do not currently include the e-paper, crossword and print.

.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.